MALVERN, Pa.--(BUSINESS WIRE)--Pennsylvania Bio (www.pennsylvaniabio.org) today issued a new report detailing research happening through Pennsylvania companies to combat rare diseases. This new Orphan Drug Report is the latest in the Pennsylvania Bio MedTRACK Patient Impact Report series.
